Sarcopenia – Age-Related Muscle Wasting and Weakness : Mechanisms and Treatments /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2011.
|
| Edición: | 1st ed. 2011. |
| Materias: |
Tabla de Contenidos:
- 1.Overview
- 2. Molecular mechanisms of muscle wasting in cancer and ageing: cachexia versus sarcopenia
- 3. Age-related remodeling of neuromuscular junctions
- 4.Motor unit remodeling during aging
- 5. Age-related decline in actomyosin structure and function
- 6. Excitation-contraction coupling in aged skeletal muscle
- 7. Mitochondrial function in aging skeletal muscle
- 8. Fibrosis and skeletal muscle aging
- 9. Nuclear apoptosis and sarcopenia
- 10. Age-related changes in the molecular regulation of skeletal muscle mass
- 11. Genetic variation and skeletal muscle traits: implications for sarcopenia
- 12. Proteomic profiling of aged skeletal muscle
- 13. Aging, exercise and muscle protein metabolism
- 14. Reactive oxygen species generation and skeletal muscle wasting – implications for sarcopenia
- 15. Exercise as a countermeasure for sarcopenia
- 16. Role of contraction-induced injury in age-related muscle wasting and weakness
- 17. Role of IGF-I signaling in age-related changes in skeletal muscle
- 18. Role of myostatin and TGF-beta signaling in skeletal muscle growth and development: implications for sarcopenia
- 19. β-Adrenergic signaling in sarcopenia and other muscle wasting disorders.